Upadacitinib for the treatment of psoriatic arthritis

Diogo Fonseca, Miguel Nogueira, Tiago Torres

Article Type

Review

Published

This article offers a review of the more recently published results on the Janus kinase inhibitor inhibitor upadacitinib and its use in the treatment of psoriatic arthritis.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.